NCT03479307 · Interventional trial
A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.
Overall registry status Completed
Phase 3
Conditions Allergic Conjunctivitis
Delaware Valley sites
- Philadelphia Eye Associates · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory